Simmons & Simmons has advised Danish biotech company Genmab on its £1.1bn licensing deal with drugs giant GlaxoSmithKline (GSK) in one of the largest…
January 17, 2007 at 07:13 PM
1 minute read
The original version of this story was published on Legalweek
Simmons & Simmons has advised Danish biotech company Genmab on its £1.1bn licensing deal with drugs giant GlaxoSmithKline (GSK) in one of the largest ever commercial agreements in the life sciences sector.
Simmons head of intellectual property Richard Binns advised longstanding client Genmab on its deal with GSK to co-develop an antibody product and release it to the market. The product could potentially be used in the treatment of certain cancers and rheumatoid arthritis.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
